Preclinical Modeling of Surgery and Steroid Therapy for Glioblastoma Reveals Changes in Immunophenotype that are Associated with Tumor Growth and Outcome.
Balint OtvosTyler J AlbanMatthew M GrabowskiDefne BayikErin E Mulkearns-HubertTomas RadivoyevitchAnja RabljenovicSarah JohnsonCharlie AndrojnaAlireza M MohammadiGene H BarnettManmeet S AhluwaliaMichael A VogelbaumPeter E FecciJustin D LathiaPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
These data reveal that prior to intervention, increased tumor volume corresponds with reduced systemic immune function and that peripheral lymphocyte counts are prognostic when steroid treatment is taken into account.